123 related articles for article (PubMed ID: 6683530)
21. [Synthesis and properties of clotrimazole and other antimycotic 1-triphenylmethylimidazoles].
Büchel KH; Draber W; Regel E; Plempel M
Arzneimittelforschung; 1972 Aug; 22(8):1260-72. PubMed ID: 4564742
[No Abstract] [Full Text] [Related]
22. Antimycotic imidazoles. 5. Synthesis and antimycotic properties of 1-[[2-aryl-4-(arylalkyl)-1,3-dioxolan-2-yl]methyl]-1H-imidazoles.
Heeres J; Van Cutsem J
J Med Chem; 1981 Nov; 24(11):1360-4. PubMed ID: 7310813
[TBL] [Abstract][Full Text] [Related]
23. [In vitro antifungal activity of omoconazole nitrate, a novel imidazone antimycotic drug, against clinical isolates from patients with cutaneous mycosis].
Uchida K; Itoyama T; Yamaguchi H
Jpn J Antibiot; 1996 Aug; 49(8):818-23. PubMed ID: 9053537
[TBL] [Abstract][Full Text] [Related]
24. Bilogical and toxicological properties of econazole, a broad-spectrum antimycotic.
Thienpont D; Van Cutsem J; Van Nueten JM; Niemegeers CJ; Marsboom R
Arzneimittelforschung; 1975 Feb; 25(2):224-30. PubMed ID: 1173036
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic efficacy of latoconazole in formulations of clinical use on experimental dermatophytosis in guinea pigs.
Oka H; Niwano Y; Ohmi T; Tanaka T; Uchida M; Yamaguchi H
Arzneimittelforschung; 1992 Mar; 42(3):345-9. PubMed ID: 1497697
[TBL] [Abstract][Full Text] [Related]
26. The effect of bifonazole on the structure of Trichophyton.
Osumi M; Yamada N; Okada J; Yamaguchi H; Hiratani T; Plempel M
Arzneimittelforschung; 1983; 33(10):1484-91. PubMed ID: 6686051
[TBL] [Abstract][Full Text] [Related]
27. Tolerability and efficacy of bifonazole in dermatomycoses.
Stettendorf S
Arzneimittelforschung; 1983; 33(5):750-4. PubMed ID: 6683554
[TBL] [Abstract][Full Text] [Related]
28. Microscopic studies of Candida albicans and Torulopsis glabrata after in vitro treatment with bifonazole. Freeze fracture electron microscopy.
Barug D; de Groot C
Arzneimittelforschung; 1983; 33(4):538-45. PubMed ID: 6347210
[TBL] [Abstract][Full Text] [Related]
29. [Miconazol nitrate, a new broad spectrum antimycotic for local therapy in dermatomycoses. II. Effect in trichophytosis, microsporia, and cutaneous candidiasis in guinea pigs].
Refai M
Mykosen; 1973 Feb; 16(2):67-8. PubMed ID: 4712323
[No Abstract] [Full Text] [Related]
30. Synthesis and antimycotic activity of alpha-aryl-beta,N-imidazolylalkyl benzyl ethers.
Tajana A; Cappelletti R; Leonardi A; Nardi D; Veronese M
Arzneimittelforschung; 1981; 31(12):2121-3. PubMed ID: 6800383
[TBL] [Abstract][Full Text] [Related]
31. Activity of SM-4470, a new imidazole derivative, against experimental fungal infections.
Ichise K; Tanio T; Saji I; Okuda T
Antimicrob Agents Chemother; 1986 Sep; 30(3):366-9. PubMed ID: 3777903
[TBL] [Abstract][Full Text] [Related]
32. Clotrimazole: a review of its antifungal activity and therapeutic efficacy.
Sawyer PR; Brogden RN; Pinder RM; Speight TM; Avery
Drugs; 1975; 9(6):424-47. PubMed ID: 1097234
[TBL] [Abstract][Full Text] [Related]
33. Comparative efficacy and tolerance of 1% bifonazole cream and bifonazole cream vehicle in patients with tinea versicolor.
Mora RG; Greer DL
Dermatologica; 1984; 169 Suppl 1():87-92. PubMed ID: 6396118
[TBL] [Abstract][Full Text] [Related]
34. In-vitro studies with four new antifungal agents: BAY n 7133, bifonazole (BAY h 4502), ICI 153,066 and Ro 14-4767/002.
Shadomy S; Espinel-Ingroff A; Kerkering TM
Sabouraudia; 1984; 22(1):7-15. PubMed ID: 6322364
[TBL] [Abstract][Full Text] [Related]
35. In vitro antifungal activities of luliconazole, a new topical imidazole.
Koga H; Nanjoh Y; Makimura K; Tsuboi R
Med Mycol; 2009; 47(6):640-7. PubMed ID: 19115136
[TBL] [Abstract][Full Text] [Related]
36. Miconazole, a broad-spectrum antimycotic agent with antibacterial activity.
Van Cutsem JM; Thienpont D
Chemotherapy; 1972; 17(6):392-404. PubMed ID: 4563141
[No Abstract] [Full Text] [Related]
37. Treatment of experimental dermatophytosis in guinea pigs: a comparative study of bifonazole and a bifonazole-hydrocortisone combination.
Shankland GS; Richardson MD
Mycoses; 1989 Mar; 32(3):139-44. PubMed ID: 2733725
[TBL] [Abstract][Full Text] [Related]
38. Assessment of in vivo activity of bifonazole against dermatophytic infection in guinea pigs on the basis of the amount of a specific fungal cell wall component chitin in the infected skin.
Uchida K; Yamaguchi H
Dermatologica; 1984; 169 Suppl 1():47-9. PubMed ID: 6526091
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic studies following systemic and topical administration of [14C]bifonazole in man.
Patzschke K; Ritter W; Siefert HM; Weber H; Wegner LA
Arzneimittelforschung; 1983; 33(5):745-50. PubMed ID: 6683553
[TBL] [Abstract][Full Text] [Related]
40. Antimycotic imidazoles. 2. Synthesis and antimycotic properties of 1-[2-(arylalkyl)-2-phenylethyl]-1H-imidazoles.
Heeres J; Mostmans JH; Cutsem JV
J Med Chem; 1977 Nov; 20(11):1511-6. PubMed ID: 915916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
